Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koji Kitamura

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Molecular Therapy. Oncology|November 13, 2024
Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effectsAiri Ishibashi, Yue Li, Yuuta Hisatomi, et al.
Japanese Journal of Clinical Oncology|August 29, 2024
Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neckKazuki Yokoyama, Koichiro Wasano, Keita Sasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 26, 2002
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary studyMunekado Kojima, Kazumi Kamoi, Osamu Ukimura, et al.
Journal for Immunotherapy of Cancer|June 20, 2025
HVJ-E links Apolipoprotein d to antitumor effectsAiri Ishibashi, Noriko Ohta, Yuko Uegaki, et al.
Surgery|December 2, 2025
Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort studyAsahi Sato, Takayuki Anazawa, Kazuyuki Nagai, et al.
Gastrointestinal Endoscopy|August 4, 2015
Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video)Noboru Hanaoka, Ryu Ishihara, Yoji Takeuchi, et al.
Annals of Surgery|March 17, 2026
Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective Study of 739 CasesKei Yamane, Kazuyuki Nagai, Takayuki Anazawa, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Molecular Therapy. Oncology|November 13, 2024
Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effectsAiri Ishibashi, Yue Li, Yuuta Hisatomi, et al.
Japanese Journal of Clinical Oncology|August 29, 2024
Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neckKazuki Yokoyama, Koichiro Wasano, Keita Sasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 26, 2002
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary studyMunekado Kojima, Kazumi Kamoi, Osamu Ukimura, et al.
Journal for Immunotherapy of Cancer|June 20, 2025
HVJ-E links Apolipoprotein d to antitumor effectsAiri Ishibashi, Noriko Ohta, Yuko Uegaki, et al.
Surgery|December 2, 2025
Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort studyAsahi Sato, Takayuki Anazawa, Kazuyuki Nagai, et al.
Gastrointestinal Endoscopy|August 4, 2015
Endoscopic submucosal dissection as minimally invasive treatment for superficial pharyngeal cancer: a phase II study (with video)Noboru Hanaoka, Ryu Ishihara, Yoji Takeuchi, et al.
Annals of Surgery|March 17, 2026
Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective Study of 739 CasesKei Yamane, Kazuyuki Nagai, Takayuki Anazawa, et al.
Pageof 7